Cell MedX Corp. Share Price Other OTC
Equities
CMXC
US15115X1072
Biotechnology & Medical Research
Sales 2022 | 0.01 0.48 | Sales 2023 | 0 0.22 | Capitalization | 6.29K 501K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 1,135,153,669 x |
Net Debt 2022 | 592K 47.16M | Net Debt 2023 | 903K 71.87M | EV / Sales 2023 | 329,116,944 x |
P/E ratio 2022 |
-9.01
x | P/E ratio 2023 |
-0.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.34% |
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 23/11/14 |
George Adams
CHM | Chairman | 76 | 22/03/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12-11 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 26/04/22 |
Joao da Costa
BRD | Director/Board Member | 59 | 07/06/20 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+47.02% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |